The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step FDA Removes 12 Peptides from 503A Category 2 Newtropin The reason peptide access is changing comes down to two regulatory categories most patients don't know exist: 503A and 503B. 503A = traditional compounding pharmacies. State licensed, patient specific prescriptions. 503B = FDA registered outsourcing Potential FDA Peptide Reclassification 2026 What It Means for Patients Beverly Hills Rejuvenation Center
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
fda 503a bulks list bpc-157 category 2 FDA Puts BPC-157, TB-500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review